Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Isaac Teitelbaum

Concepts (359)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Dialysis
60
2025
100
15.260
Why?
Kidney Failure, Chronic
45
2025
589
8.420
Why?
Peritonitis
24
2025
82
4.630
Why?
Dialysis Solutions
12
2025
23
2.550
Why?
Renal Dialysis
18
2022
461
2.230
Why?
Hyponatremia
3
2025
42
1.770
Why?
Sodium
4
2025
196
1.740
Why?
Glucans
3
2025
22
1.350
Why?
Peritoneum
6
2023
44
1.080
Why?
Kidney
8
2023
1498
1.060
Why?
Glucose
3
2025
1053
0.930
Why?
Serum Albumin
3
2022
147
0.820
Why?
Kidney Tubules, Collecting
12
1994
25
0.820
Why?
Catheter-Related Infections
2
2025
101
0.760
Why?
Peritoneal Dialysis, Continuous Ambulatory
7
2025
16
0.730
Why?
Catheters, Indwelling
6
2025
94
0.720
Why?
Acute Kidney Injury
5
2023
866
0.610
Why?
Staphylococcus capitis
1
2019
1
0.610
Why?
Coagulase
1
2019
6
0.610
Why?
Renal Insufficiency, Chronic
3
2015
640
0.580
Why?
Renal Replacement Therapy
4
2023
102
0.570
Why?
Ferric Compounds
2
2022
55
0.570
Why?
Sucrose
2
2022
113
0.560
Why?
Quality of Health Care
2
2020
702
0.550
Why?
Humans
82
2025
146342
0.550
Why?
Arginine Vasopressin
7
1997
44
0.520
Why?
Hyperphosphatemia
3
2022
15
0.520
Why?
Kidney Transplantation
3
2012
735
0.510
Why?
Staphylococcal Infections
3
2019
397
0.500
Why?
Anti-Bacterial Agents
6
2024
1942
0.500
Why?
Peritoneal Fibrosis
1
2017
2
0.500
Why?
Kidney Function Tests
4
2020
156
0.480
Why?
Uremia
2
2014
15
0.480
Why?
Patient-Centered Care
1
2020
553
0.450
Why?
Therapeutics
1
2015
14
0.440
Why?
Kidney Medulla
10
1997
28
0.430
Why?
Body Water
1
2015
23
0.430
Why?
Voriconazole
1
2015
21
0.430
Why?
beta-Cyclodextrins
1
2015
32
0.430
Why?
Phosphates
2
2022
175
0.420
Why?
Catheterization
3
2016
179
0.410
Why?
Antifungal Agents
1
2015
153
0.400
Why?
Chelating Agents
1
2014
75
0.390
Why?
Blood Pressure
1
2020
1765
0.390
Why?
GTP-Binding Proteins
6
1995
150
0.370
Why?
Type C Phospholipases
6
1992
69
0.370
Why?
Hemodialysis Solutions
1
2012
3
0.370
Why?
Acidosis
1
2013
105
0.350
Why?
Kidney Diseases
4
2021
428
0.340
Why?
Hemofiltration
2
2010
24
0.340
Why?
Hirudins
1
2010
52
0.320
Why?
Practice Patterns, Physicians'
3
2025
1408
0.310
Why?
Cyclic AMP
6
1995
208
0.300
Why?
Urea
4
2021
84
0.300
Why?
Creatinine
5
2020
511
0.290
Why?
Protein Kinase C
5
1995
250
0.290
Why?
Middle Aged
21
2025
36619
0.290
Why?
Kidney Tubules
4
1990
117
0.290
Why?
Heparin
1
2010
247
0.290
Why?
Nutritional Status
4
2022
346
0.280
Why?
Heart Diseases
1
2012
343
0.280
Why?
Glomerular Filtration Rate
5
2023
745
0.270
Why?
Infection Control
2
2025
174
0.270
Why?
Drug Resistance, Bacterial
1
2009
185
0.260
Why?
Hemodialysis, Home
4
2023
9
0.260
Why?
Peptide Fragments
1
2010
693
0.240
Why?
Survivors
1
2010
526
0.240
Why?
Prospective Studies
12
2025
8123
0.230
Why?
Scleroderma, Systemic
1
2007
124
0.230
Why?
Calcium
4
2020
1181
0.230
Why?
Cardiac Surgical Procedures
1
2012
611
0.230
Why?
Patient Selection
2
2020
728
0.230
Why?
Hernia, Abdominal
1
2005
7
0.220
Why?
Peritoneal Cavity
1
2005
30
0.220
Why?
Phosphorus
3
2022
89
0.210
Why?
Patient Participation
2
2020
457
0.210
Why?
Liver Transplantation
2
2012
751
0.210
Why?
Female
25
2025
79499
0.210
Why?
Postoperative Complications
3
2012
3034
0.210
Why?
Liver Failure
1
2005
79
0.210
Why?
Aged
15
2025
26432
0.210
Why?
Internationality
3
2020
156
0.210
Why?
Time Factors
6
2015
7109
0.200
Why?
Hemoglobins
2
2020
384
0.200
Why?
Teicoplanin
1
2024
15
0.200
Why?
Male
25
2025
73396
0.190
Why?
Dose-Response Relationship, Drug
3
2025
2022
0.190
Why?
Blood Chemical Analysis
1
2003
109
0.190
Why?
Quality Improvement
2
2023
1354
0.190
Why?
Practice Guidelines as Topic
3
2020
1591
0.180
Why?
Quality of Life
5
2020
3200
0.180
Why?
Phosphatidylinositols
3
1991
59
0.180
Why?
Device Removal
2
2019
149
0.180
Why?
Rats
13
2014
5586
0.180
Why?
Risk Factors
8
2025
10921
0.170
Why?
Contraindications, Procedure
1
2021
14
0.170
Why?
Treatment Outcome
10
2025
11821
0.170
Why?
Goals
2
2020
187
0.170
Why?
Nephrologists
1
2021
13
0.170
Why?
Patient Education as Topic
4
2025
770
0.170
Why?
Organism Hydration Status
1
2020
9
0.160
Why?
Attitude of Health Personnel
2
2020
1219
0.160
Why?
Superior Vena Cava Syndrome
1
2000
4
0.160
Why?
Chylous Ascites
1
2000
5
0.160
Why?
Epidermal Growth Factor
6
1994
157
0.160
Why?
Liver Cirrhosis
1
2003
278
0.160
Why?
Liposomes
1
2022
269
0.160
Why?
Acid-Base Equilibrium
1
2020
23
0.160
Why?
Critical Illness
4
2023
908
0.160
Why?
Blood Volume
1
2020
57
0.160
Why?
Stress, Psychological
1
2009
1171
0.150
Why?
Magnesium
1
2020
155
0.150
Why?
Potassium
1
2020
151
0.150
Why?
Patient Care Planning
1
2020
170
0.150
Why?
Cohort Studies
5
2025
6077
0.150
Why?
Physician Executives
1
2019
29
0.140
Why?
Patient Reported Outcome Measures
2
2020
516
0.140
Why?
Congresses as Topic
1
2020
226
0.130
Why?
Receptors, Vasopressin
2
1995
20
0.130
Why?
Societies, Medical
2
2020
907
0.130
Why?
Kidney Concentrating Ability
1
1997
3
0.130
Why?
Drug Combinations
2
2022
400
0.130
Why?
Survival Rate
2
2020
2092
0.130
Why?
Dogs
2
2023
517
0.130
Why?
Renal Insufficiency
1
2020
173
0.130
Why?
Data Collection
1
2020
650
0.130
Why?
Adenylyl Cyclase Inhibitors
2
1994
7
0.130
Why?
Adenylyl Cyclases
3
1993
60
0.130
Why?
Risk Assessment
4
2016
3712
0.120
Why?
Adult
18
2024
41087
0.120
Why?
United States
7
2023
16136
0.120
Why?
Antibiotic Prophylaxis
3
2025
140
0.120
Why?
Proportional Hazards Models
3
2022
1331
0.120
Why?
Survival Analysis
2
2015
1378
0.110
Why?
Hormones
2
1994
134
0.110
Why?
Models, Animal
1
2017
387
0.110
Why?
Ultrafiltration
1
2015
28
0.110
Why?
Epithelial-Mesenchymal Transition
1
2017
219
0.110
Why?
Kaplan-Meier Estimate
2
2015
970
0.100
Why?
Gastrointestinal Absorption
1
2014
6
0.100
Why?
Curriculum
1
2021
1079
0.100
Why?
Diglycerides
2
1993
66
0.100
Why?
Treatment Failure
1
2015
361
0.100
Why?
Virulence Factors, Bordetella
2
1991
15
0.100
Why?
Pertussis Toxin
2
1991
24
0.100
Why?
Phospholipases A
2
1992
97
0.100
Why?
Didanosine
1
1993
13
0.100
Why?
Biological Transport
1
2015
424
0.100
Why?
Anti-Infective Agents
1
2016
234
0.100
Why?
Lung Injury
1
2017
263
0.100
Why?
Inflammation
3
2017
2919
0.100
Why?
Cytosol
1
1994
215
0.100
Why?
Animals
17
2023
38107
0.100
Why?
Biomedical Research
1
2020
729
0.090
Why?
HIV Seropositivity
1
1993
118
0.090
Why?
Oleanolic Acid
1
2012
9
0.090
Why?
Methylene Blue
1
2012
24
0.090
Why?
Equipment Design
2
2014
520
0.090
Why?
Vascular Calcification
1
2014
109
0.090
Why?
Tissue Adhesions
1
2012
32
0.090
Why?
Palliative Care
1
2020
1032
0.090
Why?
Hematinics
1
2012
22
0.090
Why?
Delayed Graft Function
1
2012
56
0.090
Why?
Cells, Cultured
9
1994
4118
0.090
Why?
Receptors, Angiotensin
1
1991
11
0.090
Why?
Prognosis
4
2016
4351
0.080
Why?
Vasoconstrictor Agents
1
2012
148
0.080
Why?
Transplantation, Homologous
1
2012
416
0.080
Why?
Nephrectomy
1
2012
172
0.080
Why?
Atrial Natriuretic Factor
1
1991
54
0.080
Why?
Hypotension
1
2012
125
0.080
Why?
Bacterial Infections
2
2003
247
0.080
Why?
Restless Legs Syndrome
1
2011
20
0.080
Why?
Glycerides
1
1990
16
0.080
Why?
Retrospective Studies
6
2023
17438
0.080
Why?
Aluminum Compounds
1
1990
6
0.080
Why?
Phospholipases
1
1990
14
0.080
Why?
Antithrombins
1
2010
71
0.080
Why?
Membranes, Artificial
1
2010
67
0.080
Why?
Virginiamycin
1
2009
3
0.070
Why?
Models, Biological
1
2017
1761
0.070
Why?
Graft Survival
1
2012
523
0.070
Why?
Daptomycin
1
2009
18
0.070
Why?
Follow-Up Studies
4
2011
5439
0.070
Why?
Oxazolidinones
1
2009
16
0.070
Why?
Linezolid
1
2009
25
0.070
Why?
Double-Blind Method
2
2012
2070
0.070
Why?
Protein Kinases
1
1991
311
0.070
Why?
Minerals
1
2009
48
0.070
Why?
Acetamides
1
2009
42
0.070
Why?
Enzyme Inhibitors
1
2012
823
0.070
Why?
Hematuria
1
1988
11
0.070
Why?
Enzyme Activation
4
1994
759
0.070
Why?
Sympathetic Nervous System
1
1989
177
0.070
Why?
Communicable Diseases
1
2010
166
0.070
Why?
Kidney Tubular Necrosis, Acute
1
2007
26
0.070
Why?
Proteinuria
1
1988
103
0.060
Why?
Hepatorenal Syndrome
1
2007
14
0.060
Why?
Tetradecanoylphorbol Acetate
3
1993
128
0.060
Why?
Recombinant Proteins
1
2010
1361
0.060
Why?
Spondylitis, Ankylosing
1
1988
43
0.060
Why?
RNA, Messenger
1
1995
2791
0.060
Why?
Aged, 80 and over
1
2019
8391
0.060
Why?
Sleep Wake Disorders
1
2011
314
0.060
Why?
Inositol Phosphates
3
1991
21
0.060
Why?
Primary Prevention
2
2016
222
0.060
Why?
ErbB Receptors
1
1990
636
0.060
Why?
Biopsy, Needle
1
2007
183
0.060
Why?
Hemodialysis Units, Hospital
1
2005
5
0.060
Why?
Nephrology
2
2020
59
0.060
Why?
Imipenem
1
2005
16
0.060
Why?
Incidence
3
2007
2936
0.060
Why?
Kinetics
3
2017
1553
0.060
Why?
Ethics, Clinical
1
2005
9
0.060
Why?
Skin Diseases
1
2007
144
0.050
Why?
Anticoagulants
1
2010
746
0.050
Why?
Vasculitis
1
2005
69
0.050
Why?
Staphylococcus aureus
1
2009
459
0.050
Why?
Medication Adherence
1
2009
535
0.050
Why?
Capillaries
1
2005
123
0.050
Why?
Fibrosis
1
2007
568
0.050
Why?
Gastric Acid
1
2023
9
0.050
Why?
Canada
1
2005
432
0.050
Why?
Bromcresol Green
1
2003
1
0.050
Why?
Bromcresol Purple
1
2003
1
0.050
Why?
Nephelometry and Turbidimetry
1
2003
14
0.050
Why?
Hepcidins
1
2023
20
0.050
Why?
Combined Modality Therapy
1
2007
1271
0.050
Why?
Indicators and Reagents
1
2003
105
0.050
Why?
Triglycerides
1
2006
527
0.050
Why?
Permeability
1
2003
166
0.050
Why?
Drug Resistance
2
2012
145
0.050
Why?
Eosinophils
1
2006
319
0.050
Why?
Equipment Failure
1
2003
112
0.050
Why?
Vancomycin
1
2024
96
0.050
Why?
Disease Models, Animal
1
2014
4580
0.050
Why?
Inositol 1,4,5-Trisphosphate
2
1994
20
0.050
Why?
Monocytes
1
2006
538
0.050
Why?
Severity of Illness Index
2
2011
2921
0.050
Why?
Regression Analysis
1
2005
999
0.050
Why?
Health Services Accessibility
1
2011
1107
0.050
Why?
Hypoalbuminemia
1
2022
26
0.050
Why?
Cats
1
2023
226
0.050
Why?
Lung Transplantation
1
2005
326
0.040
Why?
Burns
1
2007
365
0.040
Why?
Medicare
2
2022
920
0.040
Why?
Phospholipases A2
2
1992
78
0.040
Why?
Ownership
1
2023
116
0.040
Why?
Patient Compliance
1
2006
589
0.040
Why?
Positron-Emission Tomography
1
2023
343
0.040
Why?
Guanosine 5'-O-(3-Thiotriphosphate)
2
1991
13
0.040
Why?
Guanosine Diphosphate
2
1991
20
0.040
Why?
Thionucleotides
2
1991
35
0.040
Why?
Erythrocytes
1
2006
750
0.040
Why?
Dinoprostone
2
1990
179
0.040
Why?
Recurrence
1
2003
1133
0.040
Why?
Chronic Disease
1
2005
1827
0.040
Why?
Child
3
2013
22693
0.030
Why?
Potassium, Dietary
1
1998
12
0.030
Why?
Drinking
1
1998
44
0.030
Why?
Terminology as Topic
1
2020
253
0.030
Why?
Sodium, Dietary
1
1998
43
0.030
Why?
Predictive Value of Tests
2
2017
2113
0.030
Why?
Cardiovascular Diseases
1
2010
2219
0.030
Why?
Diabetes Mellitus, Type 2
1
2012
2623
0.030
Why?
Quality Control
1
2017
163
0.030
Why?
Diabetic Nephropathies
1
2000
320
0.030
Why?
Pilot Projects
1
2022
1888
0.030
Why?
Fluid Therapy
1
2017
154
0.030
Why?
Reproducibility of Results
1
2003
3416
0.030
Why?
Prostaglandins
1
1995
94
0.030
Why?
Hospitalization
1
2006
2475
0.030
Why?
Ionomycin
1
1994
22
0.030
Why?
Quality Indicators, Health Care
1
2017
343
0.030
Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1994
165
0.030
Why?
Isoproterenol
1
1994
96
0.020
Why?
Colforsin
1
1993
47
0.020
Why?
Guanylate Cyclase
1
1992
36
0.020
Why?
Prevalence
2
2011
2861
0.020
Why?
Interleukin-6
1
2017
784
0.020
Why?
Shock, Surgical
1
2012
2
0.020
Why?
Catecholamines
1
2012
88
0.020
Why?
Intraoperative Care
1
2012
68
0.020
Why?
Poisson Distribution
1
2012
77
0.020
Why?
Sample Size
1
2012
124
0.020
Why?
Prospective Payment System
1
2011
15
0.020
Why?
Base Sequence
1
1995
2123
0.020
Why?
Total Quality Management
1
2011
59
0.020
Why?
Inositol
1
1991
26
0.020
Why?
Receptors, Oxytocin
1
1991
20
0.020
Why?
Accreditation
1
2011
100
0.020
Why?
Cyclic GMP
1
1991
88
0.020
Why?
Dideoxyadenosine
1
1990
4
0.020
Why?
Molecular Sequence Data
1
1995
2838
0.020
Why?
Oxytocin
1
1991
51
0.020
Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
1990
26
0.020
Why?
Isoquinolines
1
1990
44
0.020
Why?
Adenosine Diphosphate Ribose
1
1990
5
0.020
Why?
Fluorides
1
1990
50
0.020
Why?
Guanosine Triphosphate
1
1990
88
0.020
Why?
Aluminum
1
1990
43
0.020
Why?
Hydrolysis
1
1990
195
0.020
Why?
Rats, Sprague-Dawley
1
1995
2537
0.020
Why?
Adrenergic alpha-Agonists
1
1989
28
0.020
Why?
Adrenergic alpha-Antagonists
1
1989
34
0.020
Why?
Analysis of Variance
1
2012
1298
0.020
Why?
Health Surveys
1
2011
511
0.020
Why?
Rats, Inbred Strains
1
1989
316
0.020
Why?
Adrenergic beta-Agonists
1
1989
91
0.020
Why?
In Vitro Techniques
1
1990
1041
0.020
Why?
Glomerulonephritis, IGA
1
1988
14
0.020
Why?
Piperazines
1
1990
368
0.020
Why?
Adrenergic beta-Antagonists
1
1989
253
0.020
Why?
Clinical Trials as Topic
1
2012
1064
0.020
Why?
Cost of Illness
1
2009
323
0.020
Why?
Morbidity
1
2007
319
0.010
Why?
Research Design
1
2012
1143
0.010
Why?
Cilastatin
1
2005
2
0.010
Why?
Hemodiafiltration
1
2005
7
0.010
Why?
Drug Monitoring
1
2009
399
0.010
Why?
Biomarkers
1
2017
4340
0.010
Why?
Multivariate Analysis
1
2009
1543
0.010
Why?
Osmolar Concentration
2
1998
165
0.010
Why?
Healthcare Disparities
1
2012
733
0.010
Why?
Protease Inhibitors
1
2005
103
0.010
Why?
Biopsy
1
1988
1075
0.010
Why?
Telemedicine
1
2014
966
0.010
Why?
Sensitivity and Specificity
1
2009
1998
0.010
Why?
Comorbidity
1
2009
1665
0.010
Why?
Acute Disease
1
2007
1038
0.010
Why?
Protein Kinase Inhibitors
1
1990
983
0.010
Why?
Respiratory Function Tests
1
2005
543
0.010
Why?
Drug Therapy, Combination
1
2005
1036
0.010
Why?
Graft Rejection
1
2005
516
0.010
Why?
Immunosuppressive Agents
1
2005
829
0.010
Why?
Colorado
1
1990
4595
0.010
Why?
Mice
1
2017
18297
0.010
Why?
Lung Diseases
1
2005
787
0.010
Why?
Diet, Vegetarian
1
1998
11
0.010
Why?
Beer
1
1998
13
0.010
Why?
Urine
1
1998
63
0.010
Why?
Cross-Sectional Studies
1
2009
5899
0.010
Why?
Dietary Proteins
1
1998
135
0.010
Why?
Signal Transduction
1
1990
5246
0.010
Why?
Muscarine
1
1994
3
0.010
Why?
Carbachol
1
1994
17
0.010
Why?
Vasopressins
1
1994
60
0.010
Why?
Tyrosine
1
1994
217
0.010
Why?
Cell Polarity
1
1994
138
0.010
Why?
Purines
1
1994
188
0.010
Why?
Adolescent
1
2012
22557
0.010
Why?
Lung
1
2005
4122
0.010
Why?
Hypertonic Solutions
1
1991
7
0.010
Why?
Nocodazole
1
1991
17
0.010
Why?
Cycloheximide
1
1991
42
0.010
Why?
Isotonic Solutions
1
1991
43
0.010
Why?
Culture Media
1
1991
161
0.010
Why?
Phosphorylation
1
1994
1724
0.000
Why?
Peptides
1
1994
992
0.000
Why?
Teitelbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)